Marcus Lancé studied medicine at the Berlin Free University Medical School and the Charité (1991-1996), Germany.
In 1997, he entered his residency at the Kliniken Maria-Hilf, Department of Anaesthesiology, Mönchengladbach.
In 2001 he moved to the RWTH-Aachen University Hospital where he finalized his residency in anaesthesiology. Directly hereafter he went for the ICU fellowship which he finalized in 2003. From the RWTH-Aachen Dr. Lancé moved 2004 to Rotterdam, Thorax Centre (the Netherlands), where he gained a high degree of experience in cardiac anaesthesiology. In 2006 he went to the Departments of Anaesthesiology and Intensive Care Medicine of the Maastricht University Medical Center+ where he became head of the sub-department of cardiothoracic anaesthesia. A position he held until 2010. At that time Dr. Lancé became highly active in research. His focus of interest is coagulation and haemostasis particularly the use of laboratory assays (ROTEM and thrombingeneration) for optimization of treatment algorithms. This topic also covered his PhD thesis which he defended in 2013.
Next to several new diagnostic tests (e.g. whole blood thrombin generation test, platelet function tests) his group developed a mock circulation model in which he investigated coagulation patterns during extracorporeal circulation.
Dr. Lancé (co-)authored about 55 scientific papers among which the European guideline for treatment of perioperative bleeding, the European guideline on perioperative venous thromboembolism prophylaxis (to be published in 2017) and the Dutch guidelines on neuroaxisblockage and anticoagulation.
